Recnew Pharma Private Limited
Founded in 2017 and headquartered in Haryana, India.
2017 | Mahendragarh, Haryana (India) | Active
Recnew Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.10 M
- Revenue Growth %
- Profit Growth 62.63%
- Ebitda 136.74%
- Net Worth -10.23%
- Total Assets -6.77%
About Recnew Pharma
Recnew Pharma Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 May 2017 (Seven years and nine months 12 days old ). Its registered office is in Mahendragarh, Haryana, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.10 M.
Chander Shekhar, Rajesh, and Amit serve as directors at the Company.
Company Details
- Location
Mahendragarh, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909HR2017PTC069001
- Company No.
069001
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 May 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Trading
Other Industry
Who are the key members and board of directors at Recnew Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chander Shekhar  | Director | 16-May-2017 | Current |
| Rajesh | Director | 16-May-2017 | Current |
| Amit | Director | 16-May-2017 | Current |
Financial Performance of Recnew Pharma.
Recnew Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 62.63% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Recnew Pharma?
Unlock access to Recnew Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹1.10 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Feb 2024 | Hdfc Bank Limited | ₹1.10 M | Open |
How Many Employees Work at Recnew Pharma?
Unlock and access historical data on people associated with Recnew Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Recnew Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Recnew Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.